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a b s t r a c t
In prostate and other epithelial cancers, E-cadherin (CDH1) is downregulated inappropriately by DNA
methylation to promote an invasive phenotype. Though cancer frequently involves a reawakening of
developmental signaling pathways, whether DNA methylation of Cdh1 occurs during organogenesis has
not been determined. Here we show that DNA methylation of Cdh1 mediates outgrowth of developing
prostate ducts. During the three-day gestational window leading up to and including prostate ductal
initiation, Cdh1 promoter methylation increases and its mRNA and protein abundance decreases in
epithelium giving rise to prostatic buds. DNA methylation is required for prostate speciﬁcation, ductal
outgrowth, and branching morphogenesis. All three endpoints are impaired by a DNA methylation
inhibitor, which also decreases Cdh1 promoter methylation and increases Cdh1 mRNA and protein
abundance. A CDH1 function-blocking antibody restores prostatic identity, bud outgrowth, and
potentiates epithelial differentiation in the presence of the DNA methylation inhibitor. This is the ﬁrst
study to mechanistically link acquired changes in DNA methylation to the normal process of prostate
organogenesis. We propose a novel mechanism whereby Cdh1 promoter methylation restricts Cdh1
abundance in developing prostate epithelium to create a permissive environment for prostatic bud
outgrowth. Thus, DNA methylation primes the prostate primordium to respond to developmental cues
mediating outgrowth, differentiation and maturation of the ductal network.
& 2014 Elsevier Inc. All rights reserved.
Introduction
E-cadherin (Cdh1) ﬁne tunes cell adhesion, migration, and
intracellular signaling dynamics during epithelial development
and is a deﬁned mediator of breast, salivary gland, hair follicle,
lung and intestinal epithelial morphogenesis (Boussadia et al.,
2002; Ewald et al., 2012; Hermiston et al., 1996; Hirai et al., 1989;
Hsu et al., 2013; Jamora et al., 2003; Nanba et al., 2001; Reardon
et al., 2012; Tinkle et al., 2008; Walker et al., 2008; Young et al.,
2003). Though Cdh1 is speciﬁcally required for early embryogen-
esis (Larue et al., 1994), the need for localized control of its activity
persists throughout development and adulthood (Boussadia et al.,
2002; Hermiston et al., 1996; Reardon et al., 2012). CDH1 also
maintains mature epithelial homeostasis and its down-regulation
associates with an invasive phenotype in some cancers (van
Horssen et al., 2012).
Regulators of CDH1 expression have been identiﬁed in devel-
oping tissues, including growth factors like TGF-β and FGF,
transcriptional repressors such as Snail and Slug and other signal-
ing pathways like NOTCH and WNT (Carraro et al., 2010; Herfs
et al., 2008; Jamora et al., 2003, 2005; Sirour et al., 2011; Wang
et al., 2012). These same pathways regulate Cdh1 in epithelial
cancers, as do other regulators. One example is DNA methylation,
which frequently down-regulates Cdh1 in epithelial tumors to
create an invasive phenotype (Graff et al., 1995; Yoshiura et al.,
1995). Whether DNA methylation also controls Cdh1 expression
and epithelial behavior during organ morphogenesis has not been
investigated. Here, for the ﬁrst time we reveal a novel mechanism
whereby DNA methylation of Cdh1 is necessary for prostate
morphogenesis.
The prostate develops under the control of androgens in a region
of the pelvic urethra known as the urogenital sinus (UGS). Prostate
buds initiate as small epithelial projections that elongate into sur-
rounding stroma, undergo branching morphogenesis, and arborize
into the mature ductal network. How developing prostate ducts
elongate into surrounding stroma during normal development is a
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particularly intriguing question because it may bear mechanistic
similarities to the invasive behavior of prostate cancer. We describe
an entirely new mechanistic link between DNA methylation and
prostate ductal morphogenesis and the role of Cdh1 in this process.
Cdh1 promoter methylation increases and its mRNA and protein
abundance decrease in basal epithelial cells giving rise to prostate,
and these events are necessary for ductal outgrowth and speciﬁcation.
We propose a priming mechanism whereby DNA methylation
restricts Cdh1 abundance in cells that give rise to the prostate, thereby
creating a permissive environment for continued development and
morphogenesis of prostatic ducts. Our results are the ﬁrst to reveal a
requirement for DNAmethylation and CDH1 in prostate development,
and describe how these events are mechanistically linked to orches-
trate prostate ductal morphogenesis.
Materials and methods
Animals
C57BL/6J mice were purchased from Jackson Laboratory (Bar
Harbor, ME), housed in polysulfone cages containing corn cob
bedding and maintained on a 12 h light and dark cycle at 2575 1C
and 20–50% relative humidity. Feed (Diet 2019 for males and Diet
7002 for pregnant females, Harlan Teklad, Madison, WI, USA) and
water were available ad libitum. All procedures were approved by
the University of Wisconsin Animal Care and Use Committee
and conducted in accordance with the NIH Guide for the Care
and Use of Laboratory Animals. Females were paired overnight
with males to obtain timed-pregnant dams. The next morning was
considered 0 days post coitus (dpc). Dams were euthanized by CO2
asphyxiation.
In situ hybridization (ISH)
ISH was conducted on paraformaldehyde (PFA) ﬁxed urogenital
sinus (UGS) which were cut into sections with a cryotome or
vibrating microtome prior to staining, or stained in whole-mount
as described previously (Abler et al., 2011a, 2011b; Keil et al.,
2012a, 2012b). Detailed protocols for PCR-based riboprobe synth-
esis are available at www.gudmap.org. The staining pattern for all
riboprobes was assessed in two sections from at least three litter-
independent UGSs. Tissue sections were processed in the same
tube as a single experimental unit to allow for qualitative compar-
isons among biological replicates and among treatment groups.
Organ culture
Male or female UGSs were removed from 14 dpc embryos and
cultured for four to seven days as described previously (Vezina
et al., 2008). Media was supplemented with 10 nM 5α-
dihydrotestosterone (DHT) and one or more of the following
treatments; vehicle control (0.1% dimethyl sulfoxide, DMSO),
5 μM 5-aza-20-deoxycytidine (5AzadC, A3635, Sigma-Aldrich,
St. Louis, MO, USA), 100 μg/mL anti-CDH1 function blocking anti-
body targeting the ﬁfth ectodomain repeat (EC5) of CDH1 (U3254,
DECMA-1, Sigma-Aldrich). Media and supplements were changed
every 2 days. Sodium azide, which was found to be toxic to explant
tissue cultures (results not shown), was removed from the CDH1
blocking antibody prior to culture using a 10,000 molecular weight
cutoff dialysis cassette (Pierce, Rockford, IL, USA).
Immunohistochemistry (IHC)
Immunoﬂuorescent staining of ISH-stained and parafﬁn sec-
tions was performed as described previously (Abler et al., 2011a;
Mehta et al., 2011). Primary antibodies were diluted as follows:
1:200 rabbit anti-CDH1 (3195, Cell Signaling Technology, Beverly,
MA, USA), 1:200 rabbit anti-KI67 (Ab15580, Abcam, Cambridge,
MA, USA), 1:50 mouse anti-KRT14 (ms-115-p0, Thermo Fisher
Scientiﬁc, Waltham, MA, USA), 1:200 rabbit anti-cleaved caspase
3 (Asp 175) (9661S, Cell Signaling Technology), 1:250 rabbit anti-
AR (sc-816, Santa Cruz Biotechnology, Santa Cruz, CA, USA), 1:50
mouse anti-TRP63 (Sc-8431, Santa Cruz Biotechnology), 1:250
rabbit anti-pan cytokeratin (18-0059, Life Technologies, Grand
Island, NY, USA). Secondary antibodies were diluted as follows:
1:250 Dylight 549-conjugated goat anti-rabbit IgG (111-507-003,
Jackson ImmunoResearch, West Grove, PA, USA), 1:250 AlexaFluor
594-conjugated goat anti-rabbit IgG (A11012, Life Technologies),
1:250 Dylight 488-conjugated goat anti-mouse IgG (115-487-003,
Jackson ImmunoResearch), 1:250 Dylight 488-conjugated goat
anti-rat IgG (112-486-003, Jackson ImmonoResearch), 1:250
Dylight 488-conjugated goat anti-rabbit IgG (111-487-003, Jackson
ImmunoResearch). Labeled tissues were counterstained with 40,6-
diamidino-2-phenylindole, dilactate (DAPI), to label cell nuclei or
wheat germ agglutinin (W21505, Life Technologies) to label cell
membranes and mounted in anti-fade media (phosphate buffered
saline containing 80% glycerol and 0.2% n-propyl gallate). Whole
mount immunohistochemistry on ISH stained tissue was per-
formed as described previously (Keil et al., 2012a). Primary anti-
body was rabbit anti-CDH1 diluted 1:750 and secondary antibody
was biotin conjugated goat anti-rabbit IgG diluted at 1:500 (BA-
1000, Vector, Burlingame, CA, USA). Following ISH and IHC, some
tissues were parafﬁn embedded and sectioned as described pre-
viously (Keil et al., 2012a) and counterstained with nuclear fast
red. Brightﬁeld images were captured using an Eclipse 80i com-
pound microscope for sections and a SMZ1000 microscope for
whole mount, ﬂuorescent images were captured using an Eclipse
E600 compound microscope (Nikon Instruments Inc., Melville, NY,
USA) and merged using NIS elements imaging software (Nikon
Instruments Inc.). All treatment groups were imaged using the
same settings and captured at the same exposure.
Methylated DNA immunoprecipitation (MeDIP)
Genomic DNA was isolated using the Qiagen DNeasy Blood and
Tissue Kit (Qiagen, Valencia, CA, USA) according to manufacturer's
instructions. Two micrograms of genomic DNA was diluted into a
50 μl volume with phosphate buffered salineþ0.1% Tween 20 (PBS)
and was fragmented by 30 cycles of 30 s on, 30 s off in an ice cold
sonicating water bath (Chicago Electric 120 v/60 Hz/35W, model
3305). Agarose gel electrophoresis was used to conﬁrm efﬁcient
DNA fragmentation to an average size of 200–1000 base pairs.
Fragmented DNA was boiled for 10 min and cooled on ice for
10 min. Each sample was divided into two fractions with 10% of the
divided fraction saved as input control. 2 μg anti-mouse IgG antibody
(ab18413, Abcam) was added to one fraction, 2 μg anti-5-methyl
cytidine antibody (33D3 ab10805, Abcam) was added to the other
fraction and both fractions were incubated overnight at 4 1C. The
conjugated antibodies were captured during a 2 h incubation at 4 1C
with 30 mL/mL of Protein A Agarose/Salmon Sperm DNA Beads (#16-
157, Millipore, Billerica, MA, USA). Beads were washed with PBS,
resuspended in 100 mL of digestion buffer (50 mM Tris pH8, 10 mM
EDTA, 0.5% SDS) containing 0.4 mg/mL Proteinase K and incubated
overnight on a rotating platform at 50 1C to release the DNA. Samples
were washed twice with digestion buffer and supernatant collected.
MeDIP DNA was puriﬁed using the QIAquick PCR Puriﬁcation Kit
(Qiagen, #28104). Real time quantitative PCR (QPCR) was performed
as described previously (Keil et al., 2012b) using gene speciﬁc primers
for Cdh1: 50-CACGGAGGGAGAACAATGTAAG-30 and 50-TATGCATCCCA-
CATCCATCAG-30 (Entrez gene ID 12550, NC_000074.6). Results were
analyzed using the ΔCt method and expressed as enrichment over
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IgG (Livak and Schmittgen, 2001). Results are representative of at
least three litter independent pools of DNA with at least ﬁve tissues
per pool.
Flow cytometry
Single cell suspensions from pooled intact male 17 dpc UGSs
(3–5 UGSs/pool) were generated as described previously (Lukacs
et al., 2010). UGSs were dissected to remove seminal vesicle
rudiments and the bladder was trimmed at the bladder neck.
Cells were labeled with the following ﬂuorescently conjugated
primary antibodies: rat anti-CD49f-PE, rat anti-CD31-FITC, rat
anti-CD45-FITC and rat anti-TER119-FITC (clones: GoH3, 390, 30-
F11, and TER-119 respectively, eBioscience, San Diego, CA, USA) as
described previously (Lukacs et al., 2010), washed in 0.5% BSA/PBS,
ﬁxed in 2% PFA for 10 min and permeabilized with PBSþ0.5%
Tween 20 at room temperature for 15 min. Cells were then
incubated with unconjugated rabbit anti-CDH1 primary antibody
diluted at 1:200 (3195, Cell Signaling Technology) at room tem-
perature for 30 min, followed by incubation with APC-conjugated
goat anti-rabbit secondary antibody diluted at 1:100 (Sc-3846,
Santa Cruz) at room temperature for 30 min. Cells were washed in
PBS and stored in 2% PFA protected from light until analyzed on a
FACS Calibur ﬂow cytometer (BD Biosciences, San Jose, CA, USA).
Single antibody staining controls were used for each sample. Flow
cytometry data were analyzed using FlowJo software (TreeStar Inc.
Ashland, OR, USA).
Renal grafting
Female UGSs removed at 14 dpc were cultured for seven days
as described above in media containing 10 nM DHT and either
vehicle control (0.1% DMSO) or 5 μM 5AzadC. Tissues were then
placed under the renal capsule of intact male syngeneic (C57BL/6J)
host mice and grown for 1 month. Graft volume was calculated
using the modiﬁed ellipsoid formula of 1/2(lengthwidth2)
(Euhus et al., 1986; Tomayko and Reynolds, 1989).
Statistical analyses
Prostatic buds were counted as described previously (Keil et al.,
2012a). Prostatic bud length, from the base to the distal tip, was
measured for at least 6 buds per UGS in at least three UGSs per
treatment group. The frequency of immunolabeled Ki-67 positive,
KRT14 positive and double-positive cells was determined in at
least two sections per UGS in at least three UGSs per treatment
group. Image J software was used to determine the relative
integrated density, a measure of the sum of converted grayscale
values of the pixels in a ﬁeld, for red and green channels captured
from 3 basal epithelial ﬁelds per UGS in at least three litter
independent samples per group. Statistical analysis was performed
using R version 2.13.1. Homogeneity of variance was determined
using Levene's test. Student's t-test, ANOVA or Kruskal–Wallis test
followed by Tukey's Honestly Signiﬁcant Difference (HSD) were
used to identify signiﬁcant differences (pr0.05) between or
among treatment groups.
Results
Cdh1 mRNA and protein expression are diminished in a prostate
epithelial cell subpopulation during male prostatic bud initiation
In situ hybridization (ISH) and immunohistochemistry (IHC)
were used to visualize Cdh1mRNA and protein expression patterns
within the male and female UGS prior to (14 dpc) and during
(17 dpc) prostatic bud outgrowth in males. Prostate develops only
in male C57BL/6J mice under normal hormonal conditions (Price
and Williams-Ashman, 1961), though both sexes are competent to
form prostatic buds in response to androgens during this time
period (Bard et al., 1979; Price and Williams-Ashman, 1961;
Lasnitzki and Mizuno, 1980). IHC sections were counterstained
with the cell membrane marker wheat germ agglutinin to visua-
lize the epithelial–mesenchymal boundary and to evaluate epithe-
lial membrane density. Cdh1 is present in all epithelial cells at the
stages examined, but differs in its relative abundance among
epithelial layers (Fig. 1). Cdh1 mRNA and protein staining is
abundant and ubiquitously expressed across male and female
UGS epithelium at 14 dpc, but a graded pattern emerges in both
sexes by 17 dpc when prostatic buds are forming in C57BL/6J male
mice (Fig. 1A and B). The graded staining pattern features strong
Cdh1 staining in epithelial cells closest to the urethral lumen and
weak staining in cells closest to the basement membrane (Fig. 1C).
The weakest Cdh1 mRNA and protein staining is in prostatic bud
tips (Fig. 1). These results reveal a change in Cdh1 expression
during the window when the UGS becomes competent to form
prostate. Additional staining was used to determine that CDH1
diminishes speciﬁcally in KRT14þ basal epithelium, the epithelial
cell type present in developing prostatic buds (Fig. 2A and B), and
that is required for prostatic bud formation (Kurita et al., 2004;
Signoretti et al., 2000). Because this change is observed across
male and female UGS, it is not likely to be reliant on the presence
of testicular androgens.
We used independent markers and methodology to further
investigate the relationship between basal epithelial cell identity
and CDH1 abundance. CD49f (also known as integrin alpha 6,
Itga6) marks mature prostate basal epithelium (Lukacs et al., 2008;
Lukacs et al., 2010; Lawson et al., 2007) and we conﬁrmed it also
marks fetal prostate basal epithelium within the urethra and
developing prostate buds (Fig. 2C, inset). We conducted ﬂow
cytometry on lineage (Ter119, CD45, CD31) negative intact 17 dpc
male UGS cells to exclude erythrocytes (TER-119), hematopoetic
(CD45) and endothelial (CD31) cells. The cells were then sorted on
the basis of CD49f and CDH1 abundance. The CD49fHigh and
CDH1Low (quadrant 1) illustrate that basal epithelial cells have
low CDH1 expression (Fig. 2D), consistent with our results in Fig. 1.
The CD49fHigh and CDH1High (quadrant 2) cells likely represent
proximal rudiments of ejaculatory duct which remain even after
removal of seminal vesicle and maintain high CDH1 and CD49f
expression at this stage (Fig. 2C). The CD49fLow and CDH1Low cells
(quadrant 3) represent stromal cells and the CD49fLow and
CDH1High cells (quadrant 4) represent the non-basal cells within
the epithelium. These results in conjunction with those in Fig. 1
support the hypothesis that during prostate ductal initiation, Cdh1
mRNA and protein expression are decreased in basal epithelium
giving rise to prostatic buds.
Cdh1 promoter methylation increases in UGS epithelium during the
period of prostatic bud outgrowth
Our next objective was to determine why Cdh1 abundance
diminishes in UGS basal epithelium during prostate development.
Two factors led us to consider DNA methylation as a possible
mechanism: DNA methylation represses Cdh1 expression in pros-
tate and other cancers (Yoshiura et al., 1995, Graff et al., 1995) and
the enzymes responsible for catalyzing DNA methylation, the DNA
methyltransferases, increase in abundance at the same time and in
the same basal epithelial cell population where Cdh1 abundance
diminishes during prostate development (Keil et al., 2013). We
compared Cdh1 methylation prior to (14 dpc) and during (17 dpc)
prostatic bud formation. UGSs at both stages were treated
with trypsin, microdissected to separate epithelium from stroma
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(Fig. 3A) and the puriﬁed epithelium was analyzed by MeDIP-
QPCR. Cdh1 DNA methylation signiﬁcantly increased in UGS
epithelium between 14 and 17 dpc (Fig. 3B). Therefore, at the
same time Cdh1 abundance decreases in UGS epithelium, Cdh1
methylation increases.
DNA methylation is required for prostatic bud speciﬁcation and
outgrowth of prostate epithelium
In prostate cancer, CDH1 abundance and activity are inversely
associated with cell invasiveness and motility (Graff et al., 1995;
Yoshiura et al., 1995; van Horssen et al., 2012). We surmised that
these same cell behaviors guide prostatic bud outgrowth into
surrounding stroma. To test this hypothesis, we examined prostate
development in the presence of a DNA methylation inhibitor,
which we expected to increase CDH1 abundance and impair
prostatic bud outgrowth.
The DNA methylation inhibitor 5-aza-20-deoxycytidine
(5AzadC) interferes with testicular development (Cisneros and
Branch, 2003; Choi et al., 2013). Since associated changes in
testicular androgen synthesis would confound our study, we used
an in vitro approach that recapitulates many features of in vivo
prostate development (Doles et al., 2005) but isolates the UGS
from inﬂuences of testes and other tissues. Female 14 dpc UGSs
were used since they are naïve to high levels of circulating
androgen prior to the culture period (Vom Saal, 1989), are capable
Fig. 1. E-cadherin (Cdh1) mRNA and protein expression are diminished in a speciﬁc UGS epithelial cell subpopulation during the period of prostatic bud formation. UGS
sections were stained to visualize Cdh1 abundance within urethra and prostatic bud epithelium. (A) Male and female sagittal sections (50 μm) were stained by ISH to
visualize Cdh1 mRNA expression (purple). (B) Male and female sagittal sections (5 μm) were immunoﬂuorescently labeled to detect CDH1 (green) and cell membranes
(wheat germ agglutinin, red). (C) Schematic representation of E-cadherin mRNA and protein expressionwithin UGS epithelium prior to (14 dpc) and during (17 dpc) prostatic
bud formation. A dotted line indicates the interface between epithelium and mesenchyme, as determined by cell morphology. Arrows indicates areas of diminished
E-cadherin mRNA and protein abundance. Scalebar represents 10 μm.
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of forming prostate in the presence of androgens (Lasnitzki and
Mizuno, 1980), and form the same number of prostatic buds as
male UGSs grown under equivalent conditions in androgen-
containing medium (Keil et al., 2012a). UGS explants were grown
for seven days in a deﬁned serum-free culture medium containing
androgen, 5α-dihydrotestosterone (DHT, 10 nM) and graded con-
centrations of 5AzadC.
Tissue explants were stained to visualize CDH1 and the earliest
marker of prostate identity expressed by prostatic buds, NK-3
transcription factor, locus 1 (Nkx3-1) (Bhatia-Gaur et al., 1999;
Bieberich et al., 1996; Keil et al., 2012a; Sciavolino et al., 1997)
(Fig. 4A–E). This dual staining approach enabled us to objectively
assess whether buds expressed Nkx3-1 and were therefore appro-
priately speciﬁed as prostate, to quantify the number and length of
Fig. 2. Diminished E-cadherin (Cdh1) mRNA and protein abundance occurs in the subpopulation of basal epithelial cells during prostatic bud outgrowth. (A and B) 17 dpc
male and female UGS sagittal sections (5 μm) were immunoﬂuorescently labeled to detect E-cadherin (CDH1, red) and basal epithelial cell marker keratin 14 (KRT14, green).
Cell nuclei were stained with DAPI (blue). Scalebar 10 μm. (C) 17 dpc male UGS sagittal sections (50 μm) were stained by ISH to conﬁrm localization of Cd49f mRNA (purple)
in basal epithelium. Scalebar 100 μm, inset 50 μm. (D) Flow cytometry plot of 17 dpc UGS single cell suspensions labeled with CD49f-PE/CDH1-APC in the Lin (CD31, TER-119,
CD45) negative population. A dotted line indicates the interface between epithelium and mesenchyme, as determined by cell morphology. Arrows indicate areas of
diminished CDH1 abundance. Closed arrowheads indicate prostatic buds. Abbreviations: bl, bladder; ed, ejaculatory duct.
Fig. 3. Cdh1 promoter methylation increases in UGS epithelium during the period of prostatic bud outgrowth. (A) Schematic representation of isolating UGS epithelium.
(B) MeDIP-QPCR was conducted to quantify E-cadherin (Cdh1) methylation in isolated UGS epithelium prior to (14 dpc) and during (17 dpc) prostatic bud initiation. Results
are mean 7s.e.m, n Z3 litter independent UGS tissue pools per group. Asterisk indicates a signiﬁcant difference between 17 dpc and 14 dpc UGS epithelium (po0.05).
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buds formed in culture, and to determine whether buds under-
went branching morphogenesis, a normal aspect of continuing
ductal development. 5AzadC decreases prostatic bud length
(Fig. 4F) and reduces the number of buds with detectable Nkx3-1
staining (Fig. 4G) without changing overall number of buds formed
per UGS (Fig. 4H). 5AzadC also blocks branching morphogenesis
(Fig. 4A–E). We used an independent marker of developing
prostate identity, ectodysplasin A receptor (Edar) (Keil et al.
2012a) to conﬁrm the results observed with 5AzadC and Nkx3-1.
5AzadC also reduces the number of buds with detectable Edar
staining (Fig. S1). Together these results indicate that the DNA
methylation inhibitor, interferes with prostatic bud speciﬁcation
(expression of Nkx3-1 and Edar), elongation and branching
morphogenesis.
High concentrations of 5AzadC are capable of decreasing
proliferation, inducing apoptosis, and altering differentiation sta-
tus of cells grown in vitro (Konieczny and Emerson, 1984; Patra
et al., 2011). We determined that 5AzadC impaired bud outgrowth
without causing obvious changes in formation of basal epithelium
(Fig. S2A and B), percentage of proliferating cells within basal
epithelium, stroma or the distal most tips of buds (Fig. S2C and D),
cell death (Fig. S3A–C), androgen receptor (AR) protein expression,
or distribution of androgen responsive steroid 5 alpha reductase 2
(Srd5a2) (Abler et al., 2011a; Matsui et al., 2002) (Fig. S3D–G).
To determine if inhibition of DNA methylation during prostatic
outgrowth impairs continued glandular development, we grew
UGS explants for seven days in a deﬁned serum-free culture
medium containing androgen (10 nM DHT) and either 5μM
5AzadC or its vehicle (control), and then grew them for one month
under the renal capsule of intact adult male syngeneic (C57BL/6J)
host mice. The host mice were untreated during this period.
Control grafts develop extensive, organized prostate ductal struc-
tures with evident secretory products (Fig. 4I). 5AzadC treated
tissues are signiﬁcantly smaller (Fig. 4J) and feature smaller,
disorganized ducts with few secretions (Fig. 4K). These results
suggest that DNA methylation during the initial phases of prostate
outgrowth is required for continued prostate ductal maturation.
DNA methylation is required for appropriate CDH1 expression
in basal epithelium
We next tested if 5AzadC reduced Cdh1 DNA methylation and
increased Cdh1 abundance in UGS epithelium. To assess Cdh1 DNA
methylation, MeDIP-QPCR was conducted on isolated UGS epithe-
lium from 14 dpc female mouse UGS tissues cultured in the
presence of androgen 75AzadC (5 μM). 5AzadC signiﬁcantly
reduces Cdh1 promoter methylation (Fig. 5A) and increases Cdh1
mRNA staining intensity in basal epithelium (Fig. 5B and C). Also
Fig. 4. DNA methylation is required for proper prostate bud speciﬁcation, outgrowth, and branching in UGS explant cultures. (A–E) 14 dpc female UGSs were cultured for
7 days in media containing 5α-dihydrotestosterone (DHT, 10 nM) and increasing concentrations of the DNA methylation inhibitor 5-aza-20-deoxycytidine (5AzadC, 0–10 μM).
At the end of the culture period, tissues were stained by ISH to visualize the prostate marker NK-3 transcription factor, locus 1 (Nkx3-1, purple), counterstained by IHC with
CDH1 (red) to visualize all epithelium and imaged in a sagittal orientation. Scalebar 100 μm. Quantiﬁcation of (F) prostate bud length from tip to base, (G) percent total buds
expressing the prostate marker Nkx3-1 and (H) total prostatic bud number. (I) Following 7 day organ culture control and tissues treated with 5 μM 5AzadC were grafted
under the renal capsule of an intact male syngeneic host mouse for 1 month. Scalebar 10 mm. (J) Quantiﬁcation of graft volume in control and 5AzadC treated tissues after
1 month under the renal capsule. (K) Renal capsule grafts were parafﬁn embedded and sectioned into 5 μm sagittal sections and stained with hematoxylin and eosin.
Scalebar 100 μm. Results are presented as mean 7s.e.m, n Z3 litter independent UGSs per group. Asterisks indicate a signiﬁcant difference from control (po0.05).
Arrowheads indicate branching buds. A dotted line surrounds graft tissue. Abbreviations; bl, bladder; g, graft; k, kidney.
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within basal epithelium, 5AzadC increases relative integrated
density (sum of converted grayscale pixel values) of CDH1 protein
(green) when normalized to cell membrane density (red, unal-
tered by treatment) in 5AzadC versus control tissues (Fig. 5D).
These results reveal that 5AzadC reduces CDH1 promoter methy-
lation and increases relative CDH1 abundance in basal epithelium.
A CDH1 function-blocking antibody bypasses the requirement
for DNA methylation in prostatic bud elongation
Because 5AzadC is a non-speciﬁc DNA methylation inhibitor
and likely to reduce DNA methylation at many sites across the
genome, we next wanted to pinpoint whether Cdh1 hypomethyla-
tion and an associated increase in Cdh1 abundance are responsible
for its impairment of prostatic bud morphogenesis. Female 14 dpc
UGS explants were grown in culture media containing androgen
and either 5AzadC, a CDH1 function-blocking antibody or both
5AzadC and antibody (Fig. 6A–D). This antibody is directed against
the extracellular ﬁfth ectodomain repeat (EC5) of CDH1 which
disrupts homotypic interactions (Ozawa et al., 1990; Vestweber
and Kemler, 1985) and has been used successfully to impair CDH1
function in salivary gland and lung explant cultures (Tsao et al.,
2008; Walker et al., 2008). CDH1 function-blocking antibody
penetrates UGS stroma and localizes to its intended target in
UGS epithelium (Fig. S4). 5AzadC reduces prostatic bud length by
31% when added to culture medium without the CDH1 function
blocking antibody (Fig. 6E). Though the antibody does not inde-
pendently change prostatic bud number, length or number of
branched tips per bud in UGSs grown without 5AzadC (Fig. 6), it
restores prostatic bud outgrowth in 5AzadC-treated UGSs (com-
pare Fig. 6B–D) and increases Nkx3-1-positive bud percentage in
tissues treated with or without 5AzadC, without changing total
bud number (Fig. 6E–G). These results show that 5AzadC impairs
prostatic bud speciﬁcation and outgrowth through a CDH1 depen-
dent mechanism. This mechanism is speciﬁc to the initial phases
of prostatic development because the CDH1 function-blocking
antibody does not restore branching morphogenesis in 5AzadC-
treated UGSs (Fig. 6H–J).
Cdh1 controls the rate of prostate ductal maturation
In control UGS tissues, the CDH1 function-blocking antibody
increases the number of buds undergoing branching morphogenesis
(Fig. 6H–J), suggesting additional roles for CDH1 activity in later stages
of prostate development. The CDH1 function-blocking antibody
accelerates several hallmarks of prostate ductal maturation. It causes
Fig. 5. DNA methylation is required for appropriate E-cadherin mRNA and protein expression in basal epithelium of UGS explant cultures. (A) MeDIP-QPCR was used to
quantify E-cadherin (Cdh1) methylation in epithelium from 14 dpc UGSs cultured for 4 days in media containing 5α-dihydrotestosterone (DHT, 10 nM) alone or DHT plus the
DNA methylation inhibitor 5-aza-20-deoxycytidine (5AzadC, 5 μM). Female 14 dpc UGSs cultured for 7days in media containing DHT (10 nM) alone or DHT plus 5AzadC were
cut into 5 μm sagittal sections and (B) stained by ISH to visualize Cdh1 mRNA expression (purple) and (C) IHC to visualize CDH1 expression (green) and cell membranes
(wheat germ agglutinin, red). (D) Quantiﬁcation of relative integrated density for CDH1 (green) versus cell membrane (wheat germ agglutinin, red) within the basal-most
layer in control and 5AzadC treated UGSs. Results are presented as mean 7s.e.m, n Z3 litter independent UGS sections and tissues per group. Asterisks indicate a signiﬁcant
difference from control (po0.05). A dotted line indicates the interface between epithelium and mesenchyme, as determined by cell morphology. Arrows indicate cell layers
with altered E-cadherin mRNA and protein abundance. Scalebar 10 μm.
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precocious bud lumen formation (Fig. 7A, asterisks). Prostatic ducts do
not typically form lumens until several days after birth and are not
typically observed in 14 dpc explants cultured for seven days (Doles
et al., 2005; Keil et al., 2012a; Sugimura et al., 1986). The CDH1
function-blocking antibody also changes the pattern of basal epithe-
lium from a uniform distribution around the bud and extending into
the urethra, to a localized concentration in prostatic bud tips and
discontinuous single cell layer extending into the urethra (Fig. 7B and
C; arrowheads). The formation of a discontinuous basal epithelium is
especially striking since this pattern typically occurs postnatally in
normal prostate (Fig. 7D) at a stage much older than that achieved by
the six day organ culture. A schematic representation of how the
CDH1 function-blocking antibody alters prostate bud epithelial
organization is illustrated in Fig. 7E. Together these results suggest
that CDH1 not only impacts prostate bud speciﬁcation and outgrowth
but also the maturation and differentiation of prostatic bud epithe-
lium. Therefore Cdh1 DNA methylation not only primes UGS epithe-
lium for prostatic bud speciﬁcation and outgrowth but, permits
continued development and morphogenesis of prostatic ducts.
Discussion
Our results are the ﬁrst to establish a mechanistic link between
DNA methylation and prostate morphogenesis in addition to
providing evidence for the role of CDH1 during prostate ductal
Fig. 6. A CDH1 function-blocking antibody restores prostatic bud speciﬁcation and outgrowth in UGS explant cultures treated with a DNA methylation inhibitor. (A–D)
Female 14 dpc UGSs were cultured for 6 days in media containing 5α-dihydrotestosterone (DHT, 10 nM) and either vehicle, the DNA methylation inhibitor 5-aza-20-
deoxycytidine (5AzadC, 5 μM), an E-cadherin (CDH1) function-blocking antibody (Blocking Ab, 100 μg/mL) or both 5AzadC and Blocking Ab. Following culture, tissues were
stained by ISH for the prostatic bud marker NK-3 transcription factor, locus 1 (Nkx3-1, purple), immunohistochemically stained for CDH1 (red) to label all epithelium and
imaged in a sagittal orientation. Scalebars 100 μm. Quantiﬁcation of (E) prostatic bud length, (F) percent total Nkx3-1 positive buds, (G) total bud number, (H) total number of
buds with branches, (I) total number of branch tips and (J) branch tips per bud was conducted on cultured UGSs. Results are presented as mean 7s.e.m, n Z6 litter
independent UGS tissues per group. Insets are magniﬁed images across the length of a representative prostatic bud, a white dotted line outlines the epithelium. Lines above
bar graphs indicate a signiﬁcant difference between values (po0.05). Abbreviations; bl, bladder.
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development and maturation. We reveal Cdh1 DNA methylation
during prostate initiation is a priming event that creates a
permissive environment for outgrowth and continued morpho-
genesis of prostatic ducts during later stages of development
(Fig. 8). Our results suggest that a temporal reduction of Cdh1
activity in basal epithelium is necessary for prostatic bud matura-
tion. Prostatic bud outgrowth is impaired under conditions of
elevated CDH1 abundance (the presence of a DNA methylation
inhibitor) and restored under conditions that neutralized CDH1
activity (the presence of a blocking antibody). Prostatic buds can
form without Cdh1 methylation. However, we show that the
speciﬁc role of Cdh1 methylation is to promote bud elongation,
maintenance and acquisition of prostate identity through the
reduction of CDH1 activity. We also show that CDH1 activity
inﬂuences prostatic bud lumen formation and arrangement of
ductal epithelium. These events are needed to establish the
architecture of mature prostate glandular epithelium. Thus, ﬁne
tuning of Cdh1 expression by DNA methylation during develop-
ment, at least in part, controls the timing and sequence of several
prostate ductal maturation events.
We also provide evidence that appropriate DNA methylation
patterns are required for prostatic ductal branching morphogenesis.
Fig. 7. E-cadherin (CDH1) controls the rate of prostate ductal maturation. (A–D) Female 14 dpc UGSs were cultured for 6 days in media containing 5α-dihydrotestosterone
(DHT, 10 nM) and either vehicle, the DNA methylation inhibitor 5-aza-20-deoxycytidine (5AzadC, 5 μM), a CDH1 function-blocking antibody (Blocking Ab, 100 μg/mL) or both
5AzadC and Blocking Ab. (A) Whole mount ISH was used to visualize NK-3 transcription factor, locus 1 (Nkx3-1, purple) tissues were then cut into sagittal sections (5 μm) and
counterstained with nuclear fast red. (B–D) IHC was used to detect basal epithelial markers keratin 14 (KRT14, green) or transformation-related protein, 63 (TRP63, green),
and general epithelial marker Pan-cytokeratin (PanCK, red) in urethra and developing prostatic buds in sagittal sections (5 μm). Cell nuclei were stained with DAPI (blue)
(D) 18.5 dpc, postnatal day P20 and P50 mouse prostate sagittal sections (5 μm) were immunoﬂuorescently labeled to visualize the basal epithelial marker TRP63 (green).
(E) Schematic representation of observed changes in basal epithelial organization in UGSs cultured in the presence of CDH1 function blocking antibody. Asterisks indicate the
presence of lumens. A dotted line indicates the interface between epithelium and mesenchyme, as determined by cell morphology and epithelial staining. Closed arrowheads
indicate areas of discontinuous basal epithelium. Scalebar 10 μm.
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Approximately 20% of buds form at least one branch in UGSs cultured
for seven days in basal medium containing androgen, but branching
formation is completely inhibited by a DNA methylation inhibitor and
cannot be restored by neutralizing CDH1 activity (Figs. 4 and 6). These
results indicate a CDH1-independent role of DNA methylation in
branching morphogenesis. Focused studies on the identity of methy-
lated genes during prostatic branching morphogenesis, and the
developmental timeframe in which methylation is required, will
improve understanding of how DNA methylation functions to coor-
dinate organogenesis of the prostate and other developing organs.
A question raised by our results is whether DNA methylation
intersects or functions in parallel with other known Cdh1 tran-
scriptional regulators. Cdh1 has previously been shown to be
down-regulated by localized actions of beta-catenin (CTNNB1)
and the Snail family of genes (Jamora et al., 2003, 2005). Though
Ctnnb1 is required for formation of UGS basal epithelium and
prostatic buds, conditional deletion or activation of Ctnnb1 signal-
ing during prostatic bud formation does not appear to alter Cdh1
abundance in basal epithelium (Francis et al., 2013; Mehta et al.,
2013). These results indicate that down-regulation of Cdh1 expres-
sion in fetal prostate epithelium is likely to happen independently
of CTNNB1 function. Similarly, the Snail family of transcriptional
repressors do not localize exclusively to developing prostate basal
epithelium (gudmap.org), however some are present in this cell
population and elsewhere during prostatic bud formation. One
function of Snail family members is to down-regulate Cdh1
through chromatin modiﬁcations (Espada et al., 2011; Herranz
et al., 2008; Hou et al., 2008; Lin et al., 2010; Peinado et al., 2004).
An intriguing avenue of future study will be to identify whether
factors such as the Snail family members recruit chromatin
modiﬁers to the Cdh1 promoter during prostate development, to
ﬁne tune epithelial morphogenesis by acting in concert with or
upstream of DNA methylation.
Cdh1 promoter methylation occurs inappropriately in several
cancers, including prostate cancer, where it is associated with
tumor invasiveness (Behrens and Birchmeier, 1994; Costa et al.,
2010; Takeichi, 1993; van Horssen et al., 2012). Why CDH1
becomes methylated in cancer is not known and difﬁcult to
determine in part because of the need to capture tumor cells
precisely as DNA methylation occurs. We have revealed a speciﬁc
window during mouse prostate development (14–17 dpc) during
which Cdh1 methylation increases and Cdh1 mRNA and protein
become less abundant in cells giving rise to the prostate. Having
deﬁned the window, we are now poised to uncover mechanisms
controlling Cdh1 methylation, which may inform future studies of
how CDH1 methylation occurs inappropriately in prostate and
other cancers.
Though Cdh1 abundance diminishes in early tumor progres-
sion, it often increases in remote sites of metastases to re-establish
cell adhesion (Graff et al., 2000). This raises the question of
whether methyl marks are removed from CDH1 once prostate
development is completed. Determining if there is plasticity in
Cdh1 methylation during all stages of prostate development will
be critical in determining regulatory mechanisms for Cdh1 DNA
methylation.
The identiﬁed role of DNA methylation in priming prostate
development may also shed light on mechanisms by which
endocrine disrupting chemicals perturb prostate development in
utero. Bisphenol A and others are capable of altering prostate
development (Anway et al., 2006; Dolinoy et al., 2007; Gupta,
2000; Ho et al., 2006; Timms et al., 2005; Walker, 2011) and have
been shown to alter DNA methylation in prostate and elsewhere
(Ho et al., 2006; Tang et al., 2012; Walker, 2011). The critical
window during which CDH1 methylation occurs overlaps the
known window of action for some of these chemicals (Dolinoy
et al., 2007; Gupta, 2000; Ho et al., 2006; Tang et al., 2012), raising
questions about whether their teratogenic actions are mediated in
part through DNA methylation.
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